Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Published on by Top Pharmaceutical

Dr. Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Dr. Sarah Eliuth Ochoa Hugo at Center of Research and Assistance in Technology and Design of the State of Jalisco| Mexico

Dr. Sarah Eliuth Ochoa Hugo is a dedicated pharmaceutical chemist, biotechnologist, and researcher specializing in medical and pharmaceutical innovation. Currently pursuing her Ph.D. in Biotechnological Innovation Applied to Health at CIATEJ, she integrates her expertise in biotechnology, nanotechnology, and pharmacology to address critical challenges in cancer, Alzheimer’s disease, and medical device safety. As a lecturer at Universidad del Valle de México, she mentors future health professionals, guiding them in scientific research and publication. Alongside academia, she engages in entrepreneurial initiatives that merge scientific innovation with social impact, demonstrating her commitment to advancing healthcare through research, education, and applied technology.

Publication Profile 

Orcid

Education 

Dr. Sarah Eliuth Ochoa Hugo is currently a Ph.D. candidate in Biotechnological Innovation Applied to Health at CIATEJ, focusing on advanced biomedical solutions. She previously earned her Master of Science in Biotechnological Innovation Applied to Medical and Pharmaceutical Sciences at CIATEJ, where her thesis explored exosomal cargo in Alzheimer’s pathogenesis. Her academic foundation was built at Universidad del Valle de México, where she completed a Bachelor of Science in Pharmaceutical Chemistry and Biotechnology. There, she validated a 3D glioblastoma multiforme culture model. Complementing her degrees, she has completed certifications in pharmaceutical regulation, medical English, cancer biology, pharmacology, and advanced English proficiency.

Experience 

Dr. Sarah Eliuth Ochoa Hugo serves as an undergraduate lecturer in Health Sciences at Universidad del Valle de México, where she promotes research-oriented learning and student publications. She is co-founder of Quality Approvers, a startup advancing process optimization using Lean and Six Sigma methodologies. Previously, she worked as a Pharmaceutical Chemist and Assistant Sanitary Responsible at San Javier Hospital, ensuring pharmaceutical compliance and safety. During the pandemic, she launched Paihuenk, a social entrepreneurship project producing artisanal cosmetics to support local communities. With extensive academic and industry experience, she bridges biomedical research, pharmaceutical practice, and innovation-driven entrepreneurship in health and biotechnology.

Awards and Honors 

Dr. Sarah Eliuth Ochoa Hugo achievements are reflected through her strong academic and research portfolio, including international presentations at the Society for Neuroscience meetings in San Diego and publications in prominent journals. Her certification by COFEPRIS in pharmaceutical dispensing underscores her compliance with industry standards, while academic training from King’s College London, Monash University, and Johns Hopkins has expanded her global expertise. At Universidad del Valle de México, she has been recognized for her excellence in teaching, demonstrated. Her contributions to translational research and community-focused entrepreneurship highlight her growing academic influence.

Research Focus 

Dr. Sarah Eliuth Ochoa Hugo research focuses on cancer therapy, Alzheimer’s disease, and medical device vigilance through biotechnological innovation. She has explored 3D glioblastoma culture models, evaluated phenolic compounds for anticancer activity, and investigated exosomal cargo in Alzheimer’s disease. Her recent work integrates nanotechnology, particularly gold nanostructures, for photothermal therapies in colon cancer. Additionally, she contributes to medical device monitoring and pharmaceutical safety through technovigilance research. Her multidisciplinary approach combines molecular biology, pharmacology, and nanomedicine, aiming to design innovative therapies with clinical applications. By integrating biotechnology with applied health sciences, her work advances precision medicine, preventive care, and translational biomedical innovation.

Publication Top Notes

Hani Serag | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Hani Serag | Nanomedicine | Best Researcher Award

Director, Division of Global Partnerships at University of Texas Medical Branch (UTMB) | United States

Dr. Hani Serag is a physician and public health specialist with extensive experience in health systems research, global health, and addressing health disparities. Currently serving as Director of the Division of Global Partnerships and Assistant Professor at the Department of Population Health and Health Disparities, University of Texas Medical Branch (UTMB), he leads multiple programs on chronic disease prevention, HIV screening, and global health diplomacy. With a strong history of academic, research, and policy leadership, Dr. Serag has collaborated with international organizations, academic institutions, and civil society networks to strengthen healthcare equity, health policy, and global partnerships.

Publication Profile 

Google Scholar

Education 

Dr. Hani Serag earned his MD (M.B., B.Ch) from the Faculty of Medicine, Ain Shams University, Cairo, Egypt. He holds a Master of Public Health (MPH) degree from the School of Public Health, University of Western Cape, South Africa, focusing on health systems research, monitoring and evaluation, health promotion, and primary healthcare. He further enhanced his expertise with advanced training in epidemiology, health care finance, biostatistics, and both quantitative and qualitative public health research methods through certificate programs at Erasmus University, Rotterdam, the Netherlands. His academic training integrates medicine, epidemiology, and public health with a global and systems-oriented perspective.

Experience 

Dr. Hani Serag has held key academic and leadership roles at UTMB, including Assistant Professor in Population Health and Endocrinology and Director of Global Partnerships. He has served as Principal Investigator for programs on chronic disease prevention, HIV screening, and international educational collaborations. His professional record includes consultancy and teaching engagements with the Pan American Health Organization (PAHO) and the World Health Organization (WHO). He previously served as Global Coordinator and Associate Global Coordinator for the People’s Health Movement, leading international initiatives on primary healthcare, social determinants of health, and global health governance. His work bridges academia, policy, and practice.

Awards and Honors 

Dr. Hani Serag contributions have been recognized through academic appointments across diverse disciplines including population health, internal medicine, pediatrics, and global health. His role as an Associate Member of the Graduate Faculty at UTMB highlights his mentorship of graduate students. He has been invited by WHO and PAHO for technical consultancies, curriculum development, and training programs, reflecting his international recognition in health systems and migration health research. Through his leadership in convening UTMB’s Annual Conference on Migration and Health and directing global health education initiatives, Dr. Serag has earned respect as a distinguished public health leader advancing health equity worldwide.

Research Focus 

Dr. Hani Serag research focuses on advancing health system responsiveness, reducing disparities, and integrating preventive care into clinical settings. His work emphasizes chronic disease prevention, HIV screening, and global health governance. He has designed and implemented multi-stakeholder programs that address the social determinants of health and promote patient-centered models of care. His scholarly contributions include health policy research, health systems evaluation, and migration and health studies. He has actively developed curricula, technical reports, and peer-reviewed publications to build capacity in health equity and health policy. His ongoing research strengthens global partnerships and evidence-based strategies in population health.

Publication Top Notes

Covid-19 pandemic and the social determinants of health

Explaining covid-19 performance: what factors might predict national responses?

High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial

Improving the collection of race, ethnicity, and language data to reduce healthcare disparities: a case study from an academic medical center

Cultural diversity impacts caregiving experiences: a comprehensive exploration of differences in caregiver burdens, needs, and outcomes

Racial and geographic variation in leg amputations among Texans

Relative social standing and suicide ideation among Kenyan males: the interpersonal theory of suicide in context

Racial disparities in type of heart failure and hospitalization

Social determinants of health in countries in conflict and crises: the eastern Mediterranean perspective

Subjective social standing and conflict tactics among young Kenyan men

Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies

Enabling structural resilience of street-involved children and youth in Kenya: reintegration outcomes and the Flourishing Community model

Understanding caregiver challenges: A comprehensive exploration of available resources to alleviate caregiving burdens

Coronavirus disease 2019, diabetes, and inflammation: A systemic review

Exploring the impact of ACA on rural‐urban disparity in oral health services among US noninstitutionalized adults

The association between mental well-being and school attendance among Palestinian adolescent refugees in UNRWA schools

Nan Jiang | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Nan Jiang | Nanomedicine | Best Researcher Award

Dr. Nan Jiang, Peking University School and Hospital of Stomatology, China

Dr. Nan Jiang is a distinguished biomedical researcher with a Ph.D. from Peking University (2015) and training from Columbia University and NYU School of Medicine. 🧠🦷 Her pioneering research focuses on craniofacial development, aging, and regeneration, especially through nanomedicine and exosome technologies. 🚀🧪 She has published over 35 peer-reviewed articles and authored a book on stem cells in craniofacial regeneration 📘. With an H-index of 16 📊 and a U.S. patent on exosome-based diagnostics, Dr. Jiang is shaping the future of regenerative dentistry and tissue engineering. 🌟🧫 Her innovative work continues to impact both science and clinical practice.

Publication Profile

Scopus

Education

Dr. Nan Jiang earned her Ph.D. in 2015 from Peking University 🎓, enriched by joint training at Columbia University 🇺🇸 and a visiting scholarship at NYU School of Medicine in 2017 🏥. Her research journey is rooted in the developmental biology of craniofacial organs, exploring mechanisms of aging and regeneration 🦷⏳. She is a pioneer in unveiling how nanomedicine can modulate the bone microenvironment 🔍💊. Through interdisciplinary approaches combining stem cell science, exosomes, and tissue engineering, Dr. Jiang continues to contribute groundbreaking insights to regenerative medicine and biomedical innovation.

Professional Memberships

Dr. Nan Jiang is an active member of the International Association for Dental Research (IADR) 🌍🦷, a globally respected organization that fosters excellence in oral health research. Through her membership, she collaborates with a diverse network of scientists and clinicians, advancing the frontiers of dental and craniofacial research 🔬🤝. Her involvement in IADR provides her with valuable opportunities to share her innovative work on nanomedicine, exosomes, and tissue regeneration at international forums 🌐📢. This professional affiliation strengthens her mission to translate scientific discoveries into real-world therapeutic solutions for oral health and beyond 🧪💡.

Research Focus

Dr. Nan Jiang’s research focus lies at the intersection of regenerative medicine, craniofacial biology, and nanotechnology 🧬🧫. She is particularly recognized for her work in regenerative endodontics, leveraging exosomes, stem cells, and nanomedicine to repair and regenerate dental tissues such as the pulp-dentin complex 🦷💉. Her studies also explore osteogenesis, oral tissue aging, and bone microenvironment modulation, with a special interest in single-cell RNA sequencing for understanding tooth development at a molecular level 🧠🔍. Her multidisciplinary approach is redefining future clinical practices in oral and maxillofacial regenerative therapies 🚀🏥.

Publication Top Notes

Regenerative endodontic therapy: From laboratory bench to clinical practice

Correction: Exosomes derived from human exfoliated deciduous teeth ameliorate adult bone loss in mice through promoting osteogenesis (Journal of Molecular Histology, (2020), 51, 4, (455-466), 10.1007/s10735-020-09896-3)

Advances in tooth development studies based on single-cell RNA sequencing

Chuan Fan | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Chuan Fan | Nanomedicine | Best Researcher Award

Dr Chuan Fan,Linyi University,China

Dr. Chuan Fan 🎓🔬 is a lecturer at Linyi University’s School of Chemistry and Chemical Engineering, specializing in multifunctional hydrogel dressing systems and acoustic-driven biomarker analysis. He earned his degree from the University of Science and Technology Beijing under Prof. Xueji Zhang. With 30+ SCI- and Scopus-indexed publications and a ResearchGate citation index of 984, his research contributes to pharmacology and drug delivery. However, he is in the early stages of securing patents, grants, and industry collaborations. His work holds promise for advanced therapeutic applications, making him a strong contender for early-career research awards. 🏆📚

Publication Profile

Scopus

Academic and Professional Background

Dr. Chuan Fan 🎓 pursued his studies at the University of Science and Technology Beijing under the esteemed mentorship of Professor Xueji Zhang. Since August 2023, he has been serving as a lecturer at Linyi University’s School of Chemistry and Chemical Engineering 🏫. His research primarily focuses on multifunctional hydrogel dressing systems and acoustic-driven enrichment analysis of trace biomarkers 🧪. Through his dedication and innovation, Dr. Fan has made significant progress in his field, contributing to multiple high-quality publications in indexed journals 📚. His work continues to advance scientific knowledge and practical applications in chemical and biomedical research. 🚀

Research and Innovations

Dr. Chuan Fan has made notable contributions to his field, authoring over 30 SCI- and Scopus-indexed articles 📄, reflecting his dedication to research. His citation index on ResearchGate stands at 984 🔍, indicating a moderate academic impact. However, his research engagement appears to be in its early stages, with no completed projects and only two ongoing ones 🧪. Despite his publication record, he has yet to secure patents, editorial appointments, industry collaborations, consultancy projects, or book publications 📚. While his work is promising, further achievements in these areas could enhance his influence in the scientific community. 🌟

Contributions and Impact

Dr. Chuan Fan is dedicated to advancing pharmacology and drug delivery systems, with a focus on enhancing targeted therapies and improving patient outcomes 💊🔬. His research explores innovative methods to optimize drug efficacy and minimize side effects, contributing to the evolving landscape of precision medicine. While he asserts that his work has gained significant recognition, concrete evidence such as prestigious awards, keynote invitations, or high-impact citations remains unspecified 🏆📖. Despite this, his contributions reflect a commitment to revolutionizing drug delivery, potentially shaping future advancements in personalized treatment strategies for various medical conditions 🚀🧬.

Professional Engagements

Dr. Chuan Fan currently does not hold any professional memberships, editorial roles, or collaborative positions, which are key indicators of a researcher’s influence in the academic community 📚. Actively participating in international conferences 🌍, joining professional societies 🏛️, and engaging in research networks 🔬 would significantly enhance his professional standing. Such involvement fosters knowledge exchange, strengthens collaborations, and increases visibility within the scientific community. By contributing to peer-reviewed journals ✍️, networking with experts 🤝, and taking on leadership roles, Dr. Fan can expand his impact and establish himself as a recognized authority in his field of expertise.

Research Focus

Dr. Chuan Fan’s research focuses on biomedical materials 🧪, nanotechnology 🧫, and wound healing 🩹, particularly in developing visible light-activated Ti-MOF (titanium-metal-organic frameworks) hydrogel composites for chronic diabetic wound healing 🦶. His work integrates photocatalysis 🌞, drug delivery 💊, and biocompatible hydrogels to enhance tissue regeneration and antimicrobial effects. By loading metformin into these advanced biomaterials, Dr. Fan aims to promote faster and more effective healing of diabetic wounds, addressing a critical medical challenge. His research sits at the intersection of materials science 🏗️, biomedical engineering ⚙️, and regenerative medicine 🧬.

Publication Top Notes

Visible light-activated Ti-MOF loaded metformin-hydrogel composite dressing for accelerated chronic diabetic wound healing

Assist Prof Dr.Ashok Kumar Janakiraman| Nanomedicine| Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr.Ashok Kumar Janakiraman,Nanomedicine ,Best Researcher Award

Assist Prof Dr.Ashok Kumar Janakiraman, at UCSI University, Malaysia

 Profiles

scopus

Orcid      

📚Early Academic Pursuits :

Dr. Ashok Kumar Janakiraman’s academic journey began with a Diploma in Pharmacy (DPharm) from the Directorate of Medical Education, Madras, where he graduated with first-class honors. He then pursued a Bachelor of Pharmacy (BPharm) at The TN. Dr. M.G.R Medical University in Tamil Nadu, specializing in Pharmaceutical Sciences. His research during this period focused on the standardization of essential oils from the Genus “Jasminum,” demonstrating his early interest in pharmacognosy. Continuing his passion for pharmaceuticals, he earned a Master of Pharmacy (MPharm) from SASTRA University, Thanjavur, with distinction. His research during his master’s program involved the formulation and evaluation of Olmesartan Medoxomil and Hydrochlorothiazide combination tablets. Dr. Ashok’s academic pursuits culminated with a Ph.D. in Pharmacy (Pharmaceutics) from PRIST University-Thanjavur, where he focused on the design and evaluation of sustained release formulations of Nano Carvedilol, showcasing his expertise in pharmaceutical nanotechnology.

💼Professional Endeavors :

Dr. Ashok’s professional career began as a lecturer at UCSI University, Malaysia, in 2015, where he handled lectures, practical sessions, and tutorials for pharmacy students. His dedication to teaching and research quickly earned him a promotion to Assistant Professor in 2017. In this role, he has been instrumental in lecturing on subjects such as physical pharmacy, dosage form design, dispensing and compounding, industrial pharmacy, and formulation product development. His teaching philosophy emphasizes a hands-on approach, ensuring students gain practical experience alongside theoretical knowledge.

🔬Contributions and Research Focus :

Dr. Ashok’s research contributions are extensive and varied. His expertise lies in pharmaceutical nanotechnology, where he has focused on developing novel drug delivery systems, including topical products, oral dispersible tablets, polyherbal formulations, sustained release tablets, microspheres, and transdermal patches. His notable inventions include machines for the development and production of solid pharmaceutical products, fast-melting cocoa butter tablets, and nanocarrier systems for chronic disease treatment. These innovations have been recognized through multiple patents filed in India and Germany.

He has also contributed significantly to academic literature, authoring several book chapters on topics such as cancer epigenetics, nanomedicine, deep learning in drug formulations, and the role of artificial intelligence in pharmaceutical sciences. His work has been published by renowned publishers like Elsevier, Taylor & Francis, and Nova Science Publishers.

🏆Accolades and Recognition :

Dr. Ashok’s work has garnered significant recognition in the academic and scientific communities. He has an impressive H-index, reflecting the impact and citation frequency of his publications. He has secured several research grants, including the Fundamental Research Grant Scheme (FRGS) from the Ministry of Higher Education, Malaysia, and multiple Industry Research Grants. These grants have funded his research on green synthesis of zinc oxide loaded vinblastine nanoparticles for cancer treatment, development of polyherbal formulations for cholesterol management, and formulation of anti-aging and anti-acne serums.

🌟Impact and Influence :

Dr. Ashok’s influence extends beyond research and academia. As an examiner, editor, and reviewer, he plays a pivotal role in shaping the quality and direction of pharmaceutical research. His commitment to mentoring students and young researchers has fostered a new generation of scientists equipped with both theoretical knowledge and practical skills. His contributions to the field of pharmaceutical sciences are widely recognized, making him a respected figure in his professional community.

🌐Legacy and Future Contributions :

Looking ahead, Dr. Ashok aspires to continue his journey in pharmaceutical sciences, driven by dedication and perseverance. His future contributions are likely to further advance the fields of pharmaceutical nanotechnology and drug delivery systems. He aims to leverage his extensive experience and expertise to achieve professional growth within dynamic and innovative environments. Dr. Ashok’s legacy will be marked by his significant contributions to pharmaceutical research, his impact on students and peers, and his continuous pursuit of excellence in science and education.

✨Conclusion :

Dr. Ashok Kumar Janakiraman’s career is a testament to his dedication, expertise, and impact in the field of pharmaceutical sciences. From his early academic pursuits to his professional endeavors, contributions to research, accolades, and lasting influence, Dr. Ashok’s journey reflects a commitment to advancing knowledge and improving health outcomes through innovative research and teaching. His ongoing work and future contributions promise to further enhance the field and inspire future generations of researchers and professionals.

🎓Publication 

Fabrication and characterization of cocoa butter-based caffeine fast-melting tablets

An Overview of Various Approaches for Brain Targeted Drug Delivery System

Biodegradable polymeric insulin microneedles–a design and materials perspective review

Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets

An Expedition Towards Formulating Natural Face Serum with Garcinia mangostana (Mangosteen)